Central vein sign: comparison of multiple sclerosis and leukoaraiosis

被引:0
作者
Yavas, Huseyin Gokhan [1 ]
Sagtas, Ergin [2 ]
机构
[1] Ahi Evran Univ Kirsehir Educ & Res Hosp, Dept Radiol, Kirsehir, Turkey
[2] Pamukkale Univ, Dept Radiol, Fac Med, Denizli, Turkey
关键词
Multiple sclerosis; leukoaraiosis; susceptibility-weighted imaging; central vein sign; WHITE-MATTER LESIONS; BRAIN-LESIONS; DIAGNOSIS; MISDIAGNOSIS; MRI;
D O I
10.55730/1300-0144.5541
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/aim: Leukoaraiosis produces white matter lesions (WML) similar to multiple sclerosis (MS) on brain magnetic resonance imaging (MRI), and the distinction between these two conditions is difficult radiologically. This study aimed to investigate the role of the central vein sign (CVS) in susceptibility-weighted imaging (SWI) sequence in distinguishing MS lesions from leukoaraiosis lesions in Turkish population. Materials and methods: In this prospective study, axial SWI and sagittal three-dimensional fluid-attenuated inversion recovery (3-DFLAIR) were obtained in 374 consecutive patients. The study consisted of 169 (89 MS patients, 80 patients with leukoaraiosis) patients according to the inclusion and exclusion criteria. Two observers evaluated MR images by consensus, and observers were unaware of the patient's clinical findings. Locations (periventricular, juxtacortical, and deep white matter) and the presence of CVS were investigated for each of the lesions. Differences between patients in the leukoaraiosis and MS groups were investigated using the Mann-Whitney U test or chi-square analysis. In addition, receiver operating characteristic (ROC) analysis was used to analyze the diagnostic performance of CVS. Results: A total of 1908 WMLs (1265 MS lesions, 643 leukoaraiosis) were detected in 169 patients. The CVS was significantly higher in the MS lesions (p < 0.001). The CVS positivity rate in periventricular WMLs was higher than in juxtacortical WMLs or deep WMLs, both for all patients and for patients with MS (p < 0.001). The area under the curve (AUC) of the ROC analysis was 0.88 (95% confidence interval 0.83-0.93) for CVS in the distinction of MS lesions and leukoaraiosis. Conclusion: The presence of CVS in the SWI sequence can be used as an auxiliary finding for the diagnosis of MS in the differentiation of MS and leukoaraiosis lesions.
引用
收藏
页码:1933 / 1942
页数:10
相关论文
共 35 条
[1]   Central vein sign detected by SWI at 3 T MRI as a discriminator between multiple sclerosis and leukoaraiosis [J].
Al-Zandi, Shirin H. ;
Fayadh, Noor A. H. ;
Al-Waely, Noor K. N. .
EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2018, 49 (01) :158-164
[2]   Central vein sign for multiple sclerosis: A systematic review and meta-analysis [J].
Bhandari, A. ;
Xiang, H. ;
Lechner-Scott, J. ;
Agzarian, M. .
CLINICAL RADIOLOGY, 2020, 75 (06) :479.e9-479.e15
[3]   Differentiation of multiple sclerosis from other inflammatory disorders and cerebrovascular disease: Valus of spinal MR imaging [J].
Bot, JCJ ;
Barkhof, F ;
Nijeholt, GLA ;
van Schaardenburg, D ;
Voskuyl, AE ;
Ader, HJ ;
Pijnenburg, JAL ;
Polman, CH ;
Uitdehaag, BMJ ;
Vermeulen, EGJ ;
Castelijns, JA .
RADIOLOGY, 2002, 223 (01) :46-56
[4]   The Use of the Central Vein Sign in the Diagnosis of Multiple Sclerosis: A Systematic Review and Meta-analysis [J].
Castellaro, Marco ;
Tamanti, Agnese ;
Pisani, Anna Isabella ;
Pizzini, Francesca Benedetta ;
Crescenzo, Francesco ;
Calabrese, Massimiliano .
DIAGNOSTICS, 2020, 10 (12)
[5]   Value of 3T Susceptibility-Weighted Imaging in the Diagnosis of Multiple Sclerosis [J].
Clarke, M. A. ;
Pareto, D. ;
Pessini-Ferreira, L. ;
Arrambide, G. ;
Alberich, M. ;
Crescenzo, F. ;
Cappelle, S. ;
Tintore, M. ;
Sastre-Garriga, J. ;
Auger, C. ;
Montalban, X. ;
Evangelou, N. ;
Rovira, A. .
AMERICAN JOURNAL OF NEURORADIOLOGY, 2020, 41 (06) :1001-1008
[6]   Single Test to ARrive at Multiple Sclerosis (STAR-MS) diagnosis: A prospective pilot study assessing the accuracy of the central vein sign in predicting multiple sclerosis in cases of diagnostic uncertainty [J].
Clarke, Margareta A. ;
Samaraweera, Amal P. R. ;
Falah, Yasser ;
Pitiot, Alain ;
Allen, Christopher M. ;
Dineen, Robert A. ;
Tench, Chris R. ;
Morgan, Paul S. ;
Evangelou, Nikos .
MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (04) :433-441
[7]   Value of the central vein sign at 3T to differentiate MS from seropositive NMOSD [J].
Cortese, Rosa ;
Magnollay, Lise ;
Tur, Carmen ;
Abdel-Aziz, Khaled ;
Jacob, Anu ;
De Angelis, Floriana ;
Yiannakas, Marios C. ;
Prados, Ferran ;
Ourselin, Sebastien ;
Yousry, Tarek A. ;
Barkhof, Frederik ;
Ciccarelli, Olga .
NEUROLOGY, 2018, 90 (14) :E1183-+
[8]   Application of the 2017 Revised McDonald Criteria for Multiple Sclerosis to Patients With a Typical Clinically Isolated Syndrome [J].
de Vries, Roos M. van der Vuurst ;
Mescheriakova, Julia Y. ;
Wong, Yu Yi M. ;
Runia, Tessel F. ;
Jafari, Naghmeh ;
Samijn, Johnny P. ;
de Beukelaar, Janet W. K. ;
Wokke, Beatrijs H. A. ;
Siepman, Theodora A. M. ;
Hintzen, Rogier Q. .
JAMA NEUROLOGY, 2018, 75 (11) :1392-1398
[9]   Measuring gray matter and white matter damage in MS: why this is not enough [J].
Enzinger, Christian ;
Fazekas, Franz .
FRONTIERS IN NEUROLOGY, 2015, 6
[10]   MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines [J].
Filippi, Massimo ;
Rocca, Maria A. ;
Ciccarelli, Olga ;
De Stefano, Nicola ;
Evangelou, Nikos ;
Kappos, Ludwig ;
Rovira, Alex ;
Sastre-Garriga, Jaume ;
Tintore, Mar ;
Frederiksen, Jette L. ;
Gasperini, Claudio ;
Palace, Jacqueline ;
Reich, Daniel S. ;
Banwell, Brenda ;
Montalban, Xavier ;
Barkhof, Frederik .
LANCET NEUROLOGY, 2016, 15 (03) :292-303